NCT00555035View on ClinicalTrials.gov

GSK1349572 First Time in Human Study

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Healthy Subjects

Interventions

DRUG

GSK1349572

Trial Locations (1)

47714

GSK Investigational Site, Evansville

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY